DY

Daniel Y. Bargieri

https://orcid.org/0000-0003-2564-3742

Department of Parasitology, University of São Paulo

Affiliated withUniversity of São Paulo

Research Area

Biography

Daniel Y. Bargieri has not added Biography.
If you are Daniel Y. Bargieri and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
<em>Ookluc</em>: A <em>Plasmodium berghei</em> Line for Identifying Transmission-blocking Compounds
Publication title
2025

Other Publications

Article
Year

Vaccine| PubMed ID: 17629370

2007

Vaccine| PubMed ID: 19932669

2010

Infection and immunity| PubMed ID: 26169268

2015

Cell host & microbe| PubMed ID: 27832590

2016

Frontiers in immunology| PubMed ID: 29075260

2017

Malaria journal| PubMed ID: 29316918

2018

Frontiers in pharmacology| PubMed ID: 29559909

2018

Antimicrobial agents and chemotherapy| PubMed ID: 30181368

2018

Cell host & microbe| PubMed ID: 31071289

2019

Future medicinal chemistry| PubMed ID: 31556721

2019

Frontiers in chemistry| PubMed ID: 31824917

2019

Frontiers in immunology| PubMed ID: 32153555

The journal of venomous animals and toxins including tropical diseases| PubMed ID: 32362926

2020

Antimicrobial agents and chemotherapy| PubMed ID: 32601162

2020

ACS pharmacology & translational science| PubMed ID: 33073193

2020

Antimicrobial agents and chemotherapy| PubMed ID: 33082230

2020

ChemMedChem| PubMed ID: 33247522

2021

ACS infectious diseases| PubMed ID: 33689276

2021

Frontiers in cellular and infection microbiology| PubMed ID: 34222049

2021

Frontiers in immunology| PubMed ID: 35844531

2022

Antimicrobial agents and chemotherapy| PubMed ID: 36856421

2023

Journal of controlled release : official journal of the Controlled Release Society| PubMed ID: 37562555

2023

ACS omega| PubMed ID: 37744849

2023

ACS medicinal chemistry letters| PubMed ID: 39140064

2024

PLoS pathogens| PubMed ID: 39471233

2024

JACS Au| PubMed ID: 39483245

2024

FEBS open bio| PubMed ID: 39815669

2025